3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
12
Endometrial Neoplasms
8
Lymphatic Metastasis
5
Melanoma
4
Stomach Neoplasms
3
Uterine Cervical Neoplasms
2
Lung Neoplasms
2
Head and Neck Neoplasms
2
Colonic Neoplasms
2
Uterine Neoplasms
1
Solitary Pulmonary Nodule
1
Skull Base Neoplasms
1
Secondary Lymphedema
1
Recurrence
1
Rectal Neoplasms
1
Ovarian Neoplasms
1
Neoplasm Micrometastasis
1
Multiple Pulmonary Nodules
1
Mixed Tumor, Mesodermal
1
Lymphedema
1
Liver Neoplasms
1
Invasive Breast Cancer
1
Inflammatory Breast Neoplasms
1
Gastrointestinal Stromal Tumors
1
Gastrointestinal Diseases
1
Esophageal Neoplasms
1
Digestive System Diseases
1
Cervical Cancer Stage IB1
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Hepatocellular
1
Interventions
Radiosurgery
7
lenvatinib
5
Radiofrequency Ablation
5
Electroporation
5
Radiotherapy
3
Patient Navigation
3
Laparoscopy
3
Hepatectomy
3
Exercise
3
sintilimab
2
perflutren
2
Surgical Procedures, Operative
2
Standard of Care
2
Proton Therapy
2
Nutritional Status
2
Magnetic Resonance Spectroscopy
2
Liver Transplantation
2
Injections
2
Dextrins
2
Cryosurgery
2
Control Groups
2
Bupivacaine
2
Anesthesia, General
2
toripalimab
1
tislelizumab
1
seocalcitol
1
pembrolizumab
1
motexafin gadolinium
1
gadofosveset trisodium
1
gadobutrol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Liver Neoplasms
×
Indocyanine Green
×
Clear all
NCT05160740
2022-02-04
ICGMFITinPLC
Zhujiang Hospital
Phase NA
Unknown
348 enrolled